This animation has been created for a biotech company that has developed a breakthrough therapy in obesity and diabetes.
Gelesis100 is a first-in-class therapeutic device which is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger, resulting in reduced caloric intake and weight loss. It is administered orally as a capsulated device.
Gelesis100 is designed to trigger several important weight loss mechanisms in the stomach and small intestine.
The video begins with the introduction of the drug; showcasing its structure and key components. This is followed by a journey of the drug inside the body and how it works within the targeted areas of the body.